Pyridoxal
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
361 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 2 | 12 | 12 | 3 | 6 | 31 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 2 | 6 | 4 | 5 | 18 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 2 | — | 5 | 2 | 5 | 14 |
| Vomiting | D014839 | — | R11.1 | — | 1 | 5 | 2 | 4 | 11 |
| Nausea | D009325 | — | R11.0 | 1 | — | 3 | 2 | 4 | 10 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | 2 | 3 | 3 | 9 |
| Latent tuberculosis | D055985 | — | Z22.7 | 2 | 1 | 2 | 2 | 3 | 9 |
| Syndrome | D013577 | — | — | — | 1 | 2 | 1 | 6 | 9 |
| Neoplasms | D009369 | — | C80 | 2 | 1 | 3 | 2 | 1 | 8 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | 1 | 6 | 8 |
Show 50 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | EFO_0004272 | D64.9 | — | 2 | 1 | — | 15 | 18 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 1 | 2 | — | 5 | 8 |
| Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | 1 | 4 | 2 | — | 1 | 7 |
| Aids-related opportunistic infections | D017088 | — | — | 1 | — | 1 | — | 5 | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 3 | — | 2 | 6 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 2 | — | 3 | 6 |
| Hand-foot syndrome | D060831 | EFO_1001893 | — | — | — | 3 | — | 2 | 5 |
| Fatigue | D005221 | — | R53.83 | — | — | 1 | — | 4 | 5 |
| Hiv | D006678 | — | O98.7 | — | 1 | 3 | — | — | 4 |
| Peripheral nervous system diseases | D010523 | — | G64 | — | 2 | 1 | — | 2 | 4 |
Show 64 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | 2 | — | — | 3 | 7 |
| Depression | D003863 | — | F33.9 | 1 | 1 | — | — | 5 | 7 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 1 | — | — | 5 | 6 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 3 | — | — | 2 | 5 |
| Lymphoma | D008223 | — | C85.9 | 3 | 4 | — | — | — | 4 |
| Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | — | — | 1 | 3 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 1 | — | — | 1 | 2 |
| Autism spectrum disorder | D000067877 | — | F84.0 | — | 1 | — | — | 1 | 2 |
| Venous insufficiency | D014689 | — | — | — | 2 | — | — | — | 2 |
| Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | — | 2 | — | — | — | 2 |
Show 34 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | 2 | — | — | — | 5 | 7 |
| Cognitive dysfunction | D060825 | — | G31.84 | 1 | — | — | — | 2 | 3 |
| Allergic rhinitis | D065631 | — | J30.9 | 1 | — | — | — | 1 | 2 |
| Rhinitis | D012220 | EFO_0008521 | J31 | 1 | — | — | — | 1 | 2 |
| Heart rate | D006339 | EFO_0004326 | — | 1 | — | — | — | — | 1 |
| Biological availability | D001682 | — | — | 1 | — | — | — | — | 1 |
| Hyperkinesis | D006948 | — | — | 1 | — | — | — | — | 1 |
| Papilledema | D010211 | EFO_1001074 | H35.81 | 1 | — | — | — | — | 1 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
| Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Iron deficiencies | D000090463 | — | E61.1 | — | — | — | — | 5 | 5 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | — | — | 5 | 5 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 4 | 4 |
| Premenstrual syndrome | D011293 | — | N94.3 | — | — | — | — | 4 | 4 |
| Male infertility | D007248 | EFO_0004248 | N46 | — | — | — | — | 3 | 3 |
| Diarrhea | D003967 | — | R19.7 | — | — | — | — | 3 | 3 |
| Cognition | D003071 | EFO_0003925 | — | — | — | — | — | 3 | 3 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | — | — | — | 3 | 3 |
| Hypercholesterolemia | D006937 | — | — | — | — | — | — | 3 | 3 |
| Weight loss | D015431 | — | — | — | — | — | — | 3 | 3 |
Show 130 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
222 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use